Biomedical subjects
H F Eichenwald
Publications and source records attributed to H F Eichenwald.
A curious failure to thrive.
Explore the source record for details and available documents.
Chlamydial pneumonia: a newly recognized common disease of infancy.
Explore the source record for details and available documents.
Use of trimethoprim-sulfamethoxazole in otitis media. Reply.
Explore the source record for details and available documents.
Antimicrobial therapy in infants and children. Part I. Review of antimicrobial agents.
Explore the source record for details and available documents.
Antimicrobial therapy in infants and children. Part II. Therapy of infectious conditions.
Explore the source record for details and available documents.
[Infections of newborn infants. Crucial points and trends].
Explore the source record for details and available documents.
[Antibiotics and chemotherapeutic drugs. 4: Antimycotic agents (griseofulvin, nystatin), sulfonamides, trimethoprim-sulfamethoxazole, nitrofurantoin].
Explore the source record for details and available documents.
[Antibiotics and chemotherapeutics. 3. Streptomycin, kanamycin, tobramycin (nebcin), sisomycin, amikacin, netilmicin; polymyxine, spectinomycin, narrow-spectrum antibiotics, local antibiotics; chemotherapeutics: antituberculosis agents (isoniazide, rifampicin].
Explore the source record for details and available documents.
[Antibiotics and chemotherapeutic agents. 2. Cephalexin, caphazolin, cephapirin, cephradin, cephalosporin, erythromycin, macrolid antibiotics, lincomycin, clindamycin].
Explore the source record for details and available documents.
[Antibiotics and chemotherapeutic agents. 1. Penicillin, ampicillin, amoxillin, carbenicillin, ticarcillin, tetracycline, chloramphenicol].
Explore the source record for details and available documents.
[Diarrhea. Diagnostic and therapeutic data].
Explore the source record for details and available documents.
Erythromycin: a review of its uses in pediatric practice.
Erythromycin continues to be a valuable and useful antimicrobial agent in children. Its low index of toxicity, freedom from sensitization, and reliable absorption and when administered orally contribute to make it an attractive agent in the treatment of a variety of minor respiratory and skin infections, especially in those situations where real or potential allergy to penicillin exists. Additional major uses are in the eradication of the carrier state in whooping cough and in diphtheria, especially in those instances when oral therapy can be tolerated. Dispite use over more than two decades, resistance developing in formerly susceptible organisms has not been a problem and thus seems unlikely to become so in the future.
Respiratory infections in children.
Explore the source record for details and available documents.
Pneumonia syndromes in children.
Explore the source record for details and available documents.
Four or five drugs for most office practices.
Explore the source record for details and available documents.
Nutrition, infection and intellect.
Explore the source record for details and available documents.